Filing Details
- Accession Number:
- 0001181431-12-013828
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-02 16:08:06
- Reporting Period:
- 2012-02-29
- Filing Date:
- 2012-03-02
- Accepted Time:
- 2012-03-02 16:08:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1323854 | Warner Chilcott Plc | WCRX | Pharmaceutical Preparations (2834) | 980626948 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1476630 | Johannes Marinus Zoonen Van | C/O Warner Chilcott Corporation 100 Enterprise Drive Rockaway NJ 07866 | President, Europe/Int'l & Mkt. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, Par Value $0.01 Per Share | Acquisiton | 2012-02-29 | 4,970 | $0.00 | 151,428 | No | 4 | M | Direct | |
| Ordinary Shares, Par Value $0.01 Per Share | Disposition | 2012-03-01 | 2,485 | $17.00 | 148,943 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares, Par Value $0.01 Per Share | Performance Restricted Share Units | Disposition | 2012-02-29 | 4,970 | $0.00 | 4,970 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,910 | No | 4 | M | Direct |
Footnotes
- The reported securities are performance restricted share units, each of which represents a contingent right to receive one ordinary share of Warner Chilcott plc. Up to 25% of the performance restricted share unit award is eligible to vest and settle in each of the four years following the date of grant depending upon achievement of performance targets.
Billionaire Hedge Funds
